Pharmacological Considerations in the Interpretation of Biochemical Results in Diabetic Patients with Cardiovascular Complications.
Blessing Kenechi Myke-MbataBruno BasilJeremiah John OlocheAmarachukwu IgbomPublished in: EJIFCC (2023)
Diabetes mellitus with cardiovascular diseases is often a multi-systemic disease that requires a multi-therapeutic approach which mostly poses a challenge to laboratory result interpretation. The non-availability of information on many patients due to poor referral, documentation and record keeping has resulted in isolated interpretation of laboratory result of diabetic patients with multisystemic complications. This has led to both analytical and post-analytical errors which has a negative impact on total quality of results. Therefore, this review showed the possible therapeutic treatment of a diabetic patient with cardiovascular disease and how their pharmacological role could affect laboratory result.
Keyphrases
- cardiovascular disease
- type diabetes
- wound healing
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- risk factors
- primary care
- prognostic factors
- case report
- electronic health record
- emergency department
- glycemic control
- patient reported outcomes
- skeletal muscle
- mass spectrometry
- patient reported
- drug induced